Predicting death or recurrence of portal hypertension symptoms after TIPS procedures.

Background: Accurate prediction of portal hypertension recurrence after transjugular intrahepatic portosystemic shunt (TIPS) placement will improve clinical decision-making.Purpose: To evaluate if perioperative variables could predict disease-free survival (DFS) in cirrhotic patients with portal hyp...

Descripción completa

Detalles Bibliográficos
Publicado en:European Radiology Vol. 32; no. 5; pp. 3346 - 3358
Autores principales: Sun, Shawn H., Eche, Thomas, Dorczynski, Chloé, Otal, Philippe, Revel-Mouroz, Paul, Zadro, Charline, Partouche, Ephraim, Fares, Nadim, Maulat, Charlotte, Bureau, Christophe, Schwartz, Lawrence H., Rousseau, Hervé, Dercle, Laurent, Mokrane, Fatima-Zohra
Formato: Journal Article
Publicado: Springer Nature May2022
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=156502814&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 156502814
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09387994
        NPH
      jtl: European Radiology
      issn: 09387994
      maglogo: N
    pubinfo:
      dt: May2022
      vid: 32
      iid: 5
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        156502814
        156502814
        NLM35015124
        10.1007/s00330-021-08437-0
        NLM35015124
        156502814
      ppf: 3346
      ppct: 12
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Predicting death or recurrence of portal hypertension symptoms after TIPS procedures.
      aug:
        au:
          Sun, Shawn H.
          Eche, Thomas
          Dorczynski, Chloé
          Otal, Philippe
          Revel-Mouroz, Paul
          Zadro, Charline
          Partouche, Ephraim
          Fares, Nadim
          Maulat, Charlotte
          Bureau, Christophe
          Schwartz, Lawrence H.
          Rousseau, Hervé
          Dercle, Laurent
          Mokrane, Fatima-Zohra
        affil: Department of Radiology, Columbia University Vagellos College of Physicians and Surgeons, 10032, New York, NY, USA
      sug:
        subj:
          Hypertension, Portal Surgery
          Portasystemic Shunt, Surgical
          Stents
          Retrospective Design
          Liver Cirrhosis Surgery
          Liver Cirrhosis Complications
          Treatment Outcomes
          Middle Age
          Scales
          Middle Aged: 45-64 years
      ab: Background: Accurate prediction of portal hypertension recurrence after transjugular intrahepatic portosystemic shunt (TIPS) placement will improve clinical decision-making.Purpose: To evaluate if perioperative variables could predict disease-free survival (DFS) in cirrhotic patients with portal hypertension (PHT) treated with TIPS.Materials and Methods: We recruited 206 cirrhotic patients with PHT treated with TIPS, randomly assigned to training (n = 138) and validation (n = 68) sets. We recorded 7 epidemiological, 4 clinical, and 9 radiological variables. TIPS-distal end positioning (TIPS-DEP) measured the distance between the distal end of the stent and the hepatocaval junction on contrast-enhanced CT scans. In the training set, the signature was defined as the random forest for survival algorithm achieving the lowest error rate for the prediction of DFS which was landmarked 4 weeks after the TIPS procedure. In the training set, a simple to use scoring system was derived from variables selected by the signature. The primary endpoint was to assess if TIPS-DEP was associated with DFS. The secondary endpoint was to validate the scoring system in the validation set.Results: Overall, patients with TIPS-DEP ≥ 6 mm (n = 49) had a median DFS of 24.5 months vs. 72.8 months otherwise (n = 157, p = 0.004). In the training set, the scoring system was calculated by adding age ≥ 60 years old, Child-Pugh B or C, and TIPS-DEP ≥ 6 mm (1 point each) since the signature showed high DFS probability at 6.5 months post-landmark in patients that did not meet these criteria: 86%, 80%, and 78%, respectively. The hazard ratio [95 CI] between patients determined to be low-risk (< 2 points) and high-risk (≥ 2 points) was 2.30 [1.35-3.93] (p = 0.002) in the training set and 2.01 [0.94-4.32] (p = 0.072) in the validation set.Conclusion: TIPS-DEP is an actionable radiological biomarker which can be combined with age and Child-Pugh score to predict death or PHT symptom recurrence after TIPS procedure.Key Points: • TIPS-DEP measurement was the third most important but only actionable variable for predicting DFS. • TIPS-DEP < 6 mm was associated with a DFS probability of 78% at 6.5 months post-landmark. • A simple scoring system calculated using age, Child-Pugh score, and TIPS-DEP predicted DFS after TIPS.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N